Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income 876 M833 M1.01 B891 M168 M 2.9 B Non-Operating Income, Total -257 M-190 M269 M-2 M-169 M -92 M Interest expense, net of interest capitalized 44 M49 M47 M43 M49 M 188 M Non-Operating Income, excl. Interest Expenses -301 M-239 M222 M-45 M-218 M -280 M Unusual income/expense ————— — Pretax income -258 M192 M337 M156 M20 M 705 M Equity in earnings ————— — Taxes -55 M38 M119 M-115 M17 M 59 M Non-controlling/minority interest 3 M2 M-1 M—— — After tax other income/expense ————— — Net income before discontinued operations -206 M152 M219 M368 M-1 M 738 M Discontinued operations ————0 — Net income -206 M152 M219 M368 M-1 M 738 M Dilution adjustment 000—0 — Preferred dividends 30 M11 M11 M—6 M — Diluted net income available to common stockholders -236 M141 M208 M356 M-7 M 698 M Basic earnings per share (Basic EPS) ————— — Diluted earnings per share (Diluted EPS) ————— — Average basic shares outstanding ————— — Diluted shares outstanding ————— — EBITDA 928 M871 M1.05 B936 M207 M 3.06 B EBIT 876 M833 M1.01 B1.34 B168 M 3.35 B Cost of revenue 1.19 B1.14 B891 M-65 M1.23 B 3.19 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 52 M38 M35 M45 M39 M 157 M